Impel Pharmaceuticals Inc. (IMPL) Earnings
|
Expand Research on IMPL
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -8.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -11.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3/22/24 | Q324 | N/A | -$0.21 | N/A | N/A | $9.7M | N/A | N/A | N/A | ||
| 11/27/23 | Q224 | N/A | -$0.36 | N/A | N/A | $8M | N/A | N/A | N/A | ||
| 11/20/23 | Q224 | N/A | -$0.36 | N/A | N/A | $8M | N/A | N/A | N/A | ||
| 11/13/23 | Q224 | N/A | -$0.36 | N/A | N/A | $8M | N/A | N/A | N/A | ||
| 8/28/23 | Q124 | N/A | -$0.55 | N/A | N/A | $6.3M | N/A | N/A | N/A | ||
| 8/21/23 | Q124 | N/A | -$0.55 | N/A | N/A | $6.67M | N/A | N/A | N/A | ||
| 8/14/23 | Q124 | N/A | -$0.55 | N/A | N/A | $6.67M | N/A | N/A | N/A | ||
| 6/5/23 | Q423 | N/A | -$0.92 | N/A | N/A | $5.05M | N/A | N/A | N/A |
